Table of Contents Author Guidelines Submit a Manuscript
Tuberculosis Research and Treatment
Volume 2017, Article ID 1702578, 6 pages
https://doi.org/10.1155/2017/1702578
Review Article

The Bidirectional Relationship between Tuberculosis and Diabetes

1Endocrine & Diabetes Unit, Department of Medicine and Therapeutics, School of Medicine and Dentistry, College of Health Sciences, University of Ghana, Legon, Accra, Ghana
2Directorate of Medicine, Endocrine and Diabetes Unit, Komfo Anokye Teaching Hospital, Kumasi, Ghana
3Department of Medicine and Therapeutics, School of Medicine and Dentistry, College of Health Sciences, University of Ghana, Legon, Accra, Ghana

Correspondence should be addressed to Ernest Yorke; moc.oohay@muivolvap

Received 11 August 2017; Revised 25 September 2017; Accepted 17 October 2017; Published 12 November 2017

Academic Editor: Tom Ottenhoff

Copyright © 2017 Ernest Yorke et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, “Global Tuberculosis Report,” Tech. Rep., World Health Organization, 2016. View at Google Scholar
  2. Atlas IDFD, 7th edition, International Diabetes Federation, 2016.
  3. A. K. Niazi and S. Kalra, “Diabetes and tuberculosis: a review of the role of optimal glycemic control,” Journal of Diabetes and Metabolic Disorders, vol. 11, no. 1, article 28, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Baghaei, M. Marjani, P. Javanmard, P. Tabarsi, and M. R. Masjedi, “Diabetes mellitus and tuberculosis facts and controversies,” Journal of Diabetes and Metabolic Disorders, vol. 12, no. 1, article 58, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Ruslami, R. E. Aarnoutse, B. Alisjahbana, A. J. A. M. Van Der Ven, and R. Van Crevel, “Implications of the global increase of diabetes for tuberculosis control and patient care,” Tropical Medicine & International Health, vol. 15, no. 11, pp. 1289–1299, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Morton, Phthisiolgia: Or a Treatise of Consumptions, Smith and Walford, London, UK, 1694.
  7. S. Rajalakshmi and G. Veluchamy, “Yugi's pramegam and diebetes mellitus: an analogue.,” Bulletin of the Indian Institute of History of Medicine (Hyderabad), vol. 29, no. 1, pp. 83–87, 1999. View at Google Scholar · View at Scopus
  8. R. M. Wilson, “Infection and diabetes mellitus,” in Textbook of Diabetes, J. C. Pickup and G. Williams, Eds., pp. 813–819, Blackwell Scientific Publication, Oxford, UK, 1991. View at Google Scholar
  9. G. P. Nichols, “Diabetes among young tuberculous patients; a review of the association of the two diseases,” American Review of Tuberculosis, vol. 76, no. 6, pp. 1016–1030, 1957. View at Google Scholar
  10. C. R. Stevenson, J. A. Critchley, N. G. Forouhi et al., “Diabetes and the risk of tuberculosis: A neglected threat to public health?” Chronic Illness, vol. 3, no. 3, pp. 228–245, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Y. Jeon and M. B. Murray, “Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies,” PLoS Medicine, vol. 5, no. 7, Article ID 0050152, 2008. View at Google Scholar
  12. B. Alisjahbana, E. Sahiratmadja, E. J. Nelwan et al., “The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis,” Clinical Infectious Diseases, vol. 45, no. 4, pp. 428–435, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Feleke, J. Abdulkadir, and G. Aderaye, “Prevalence and clinical features of tuberculosis in Ethiopian diabetic patients,” East African Medical Journal, vol. 76, no. 7, pp. 361–364, 1999. View at Google Scholar · View at Scopus
  14. A. B. M. Swai, D. G. Mclarty, and F. Mugusi, “Tuberculosis in diabetic patients in tanzania,” Tropical Doctor, vol. 20, no. 4, pp. 147–150, 1990. View at Publisher · View at Google Scholar · View at Scopus
  15. B. I. Restrepo, S. P. Fisher-Hoch, J. G. Crespo et al., “Type 2 diabetes and tuberculosis in a dynamic bi-national border population,” Epidemiology & Infection, vol. 135, no. 3, pp. 483–491, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. Shaikh, R. Singla, N. B. Khan, N. S. Sharif, and M. O. Saigh, “Does diabetes alter the radiological presentation of pulmonary tuberculosis,” Saudi Medical Journal, vol. 24, no. 3, pp. 278–281, 2003. View at Google Scholar · View at Scopus
  17. J.-Y. Wang, L.-N. Lee, and P.-R. Hsueh, “Factors changing the manifestation of pulmonary tuberculosis,” The International Journal of Tuberculosis and Lung Disease, vol. 9, no. 7, pp. 777–783, 2005. View at Google Scholar · View at Scopus
  18. F. Mugusi, A. B. M. Swai, K. G. M. M. Alberti, and D. G. McLarty, “Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania,” Tuberculosis, vol. 71, no. 4, pp. 271–276, 1990. View at Publisher · View at Google Scholar · View at Scopus
  19. S. K. Heysell, J. L. Moore, S. J. Keller, and E. R. Houpt, “Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program, Virginia, USA,” Emerging Infectious Diseases, vol. 16, no. 10, pp. 1546–1553, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. J.-T. Chang, H.-Y. Dou, C.-L. Yen et al., “Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance,” Journal of the Formosan Medical Association, vol. 110, no. 6, pp. 372–381, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. K. E. Dooley and R. E. Chaisson, “Tuberculosis and diabetes mellitus: convergence of two epidemics,” The Lancet Infectious Diseases, vol. 9, no. 12, pp. 737–746, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. K. E. Dooley, T. Tang, J. E. Golub, S. E. Dorman, and W. Cronin, “Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis,” The American Journal of Tropical Medicine and Hygiene, vol. 80, no. 4, pp. 634–639, 2009. View at Google Scholar · View at Scopus
  23. R. Singla, N. Khan, N. Al-Sharif, M. O. Al-Sayegh, M. A. Shaikh, and M. M. Osman, “Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients,” The International Journal of Tuberculosis and Lung Disease, vol. 10, no. 1, pp. 74–79, 2006. View at Google Scholar · View at Scopus
  24. K. Kameda, S. Kawabata, and N. Masuda, “Follow-up study of short course chemotherapy for pulmonary tuberculosis complicated with diabetes mellitus,” Kekkaku, vol. 65, no. 12, pp. 791–803, 1990. View at Google Scholar · View at Scopus
  25. M. A. Baker, A. D. Harries, C. Y. Jeon et al., “The impact of diabetes on tuberculosis treatment outcomes: a systematic review,” BMC Medicine, vol. 9, article 81, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Reis-Santos, T. Gomes, R. Locatelli et al., “Treatment outcomes in tuberculosis patients with diabetes: A polytomous analysis using Brazilian surveillance system,” PLoS ONE, vol. 9, no. 7, Article ID e100082, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Young, C. J. Wotton, J. A. Critchley, N. C. Unwin, and M. J. Goldacre, “Increased risk of tuberculosis disease in people with diabetes mellitus: record-linkage study in a UK population,” Journal of Epidemiology & Community Health, vol. 2010, Article ID 114595, 2010. View at Google Scholar
  28. P. O. Oluboyo and R. T. Erasmus, “The significance of glucose intolerance in pulmonary tuberculosis,” Tuberculosis, vol. 71, no. 2, pp. 135–138, 1990. View at Publisher · View at Google Scholar · View at Scopus
  29. O. K. Basoglu, F. Bacakoglu, G. Cok, A. Saymer, and M. Ates, “The oral glucose tolerance test in patients with respiratory infections,” Monaldi Archives for Chest Disease, vol. 54, pp. 307–310, 1999. View at Google Scholar
  30. C. Y. Jeon, A. D. Harries, M. A. Baker et al., “Bi-directional screening for tuberculosis and diabetes: A systematic review,” Tropical Medicine & International Health, vol. 15, no. 11, pp. 1300–1314, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Guptan and A. Shah, “Tuberculosis and diabetes: an appraisal,” Indian Journal of Tuberculosis, vol. 47, no. 3, pp. 2–8, 2000. View at Google Scholar
  32. V. Bansal, N. E. Asmar, W. R. Selman, and B. M. Arafah, “Pitfalls in the diagnosis and management of Cushing's syndrome,” Neurosurgical Focus, vol. 38, no. 2, article E4, 2015. View at Publisher · View at Google Scholar
  33. S. L. Atkin, E. A. Masson, C. W. Bodmer, B. A. Walker, and M. C. White, “Increased Insulin Requirement in a Patient with Type 1 Diabetes on Rifampicin,” Diabetic Medicine, vol. 10, no. 4, pp. 392–392, 1993. View at Publisher · View at Google Scholar · View at Scopus
  34. H. E. Lebovitz, Oral Hypoglycemic Agents. Ellenberg and Rifkins’S Diabetes Mellitus, H. Rifkin and D. Porte Jr., Eds., Elsevier, New York, NY, USA, 4th edition, 1990.
  35. S. E. Geerlings and A. I. Hoepelman, “Immune dysfunction in patients with diabetes mellitus (DM),” FEMS Immunology & Medical Microbiology, vol. 26, no. 3-4, pp. 259–265, 1999. View at Publisher · View at Google Scholar
  36. K. Tsukaguchi, T. Yoneda, M. Yoshikawa et al., “Case study of interleukin-1.β, tumor necrosis factor.ALPHA. and interleukin-6 production peripheral blood monocytes patients diagnosed with diabetes mellitus complicated by pulmonary tuberculosis,” kekkaku(tuberculosis), vol. 67, no. 12, pp. 755–760, 1992. View at Publisher · View at Google Scholar · View at Scopus
  37. E. H. Sidibé, “Diabète et tuberculose pulmonaire : aspects épidémiologiques, physiopathologiques et symptomatologiques,” Cahiers d'Études et de Recherches Francophones / Santé, vol. 17, no. 1, pp. 29–32, 2007. View at Publisher · View at Google Scholar
  38. M. P. Moutschen, A. J. Scheen, and P. J. Lefebvre, “Impaired immune responses in diabetes mellitus: Analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections,” Diabetes & Metabolism, vol. 18, no. 3, pp. 187–201, 1992. View at Google Scholar · View at Scopus
  39. P. J. Geevarghese, Pancreatic Diabetes, Popular Prakasha, Bombay, India, 1967.
  40. M. B. Zack, L. L. Fulkerson, and E. Stein, “Glucose intolerance in pulmonary tuberculosis,” American Review of Respiratory Disease, vol. 108, no. 5, pp. 1164–1169, 1973. View at Google Scholar
  41. F. Aguiree, A. Brown, N. H. Cho et al., IDF Diabetes Atlas, 2013.
  42. K. Venkatesan, “Pharmacokinetic drug interactions with rifampicin,” Clinical Pharmacokinetics, vol. 22, no. 1, pp. 47–65, 1992. View at Publisher · View at Google Scholar · View at Scopus
  43. W. C. Duckworth, R. G. Bennett, and F. G. Hamel, “Insulin degradation: Progress and potential,” Endocrine Reviews, vol. 19, no. 5, pp. 608–624, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Madsbad, “Treatment of type 2 diabetes with incretin-based therapies,” The Lancet, vol. 373, no. 9662, pp. 438-439, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. American Diabetes A, “Standards of Medical Care in Diabetes—2016 Abridged for Primary Care Providers,” Clinical Diabetes, vol. 34, no. 1, pp. 3–21, 2016. View at Publisher · View at Google Scholar
  46. D. Beran, M. Ewen, and R. Laing, “Constraints and challenges in access to insulin: A global perspective,” The Lancet Diabetes & Endocrinology, vol. 4, no. 3, pp. 275–285, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. A. L. Riza, F. Pearson, C. Ugarte-Gil et al., “Clinical management of concurrent diabetes and tuberculosis and the implications for patient services,” The Lancet Diabetes & Endocrinology, vol. 2, no. 9, pp. 740–753, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. World Health Organisation, Collaborative framework for care and control of tuberculosis and diabetes, 2011.